RxDoctor Payments Data

Jeffrey Marks, MD

Surgery · Cleveland, OHNPI 1881614501

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $31,400 of the $42,170 with a category attached, or 74.5%. Boston Scientific accounts for 89.4% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2020 at $23,883 and has fallen 95.9% since, to $969 in 2025. Among surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$42,170in general payments, 2019–2025

Across 120 payments — averaging $351.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$38K
  • US Endoscopy$750
  • Davol Inc.$433
  • Lumendi LLC$400
  • Aroa Biosurgery Incorporated$388
  • TELA Bio, Inc.$307
  • plus $2K from 26 others

What the payments were for

  • Consulting fees$4,37510%
  • Speaking & faculty fees$31,40074%
  • Travel & lodging$2,0505%
  • Food & beverage$4,23510%
  • Education$1100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,170 in reported general payments places this provider in the 95th percentile of 988 surgery providers in Ohio.

See all surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$59,433
Medicare patients
123
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium38$375
Nystatin38$163
Lansoprazole12$120
Fluconazole39$70

Paid to pharmacies, not to this prescriber.

Other surgery in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →